MD Anderson Cancer Center
New Drug May Work for Patients Out of Options
Ponatinib helps chronic myeloid leukemia patients with resistant disease in a Phase I clinical trial presented at the American Society of Hematology 52nd annual meeting in Orlando.
Video is loading...
Title: New Drug May Work for Patients Out of Options
Summary: Ponatinib helps chronic myeloid leukemia patients with resistant disease in a Phase I clinical trial presented at the American Society of Hematology 52nd annual meeting in Orlando.
Keywords: Chronic myeloid leukemia, cml, cortez, md anderson, cancer
Transcript: